As reported in the Cancer Letter, Georgetown Lombardi Comprehensive Cancer Center released a study that may show immunotherapy offers similar benefit to cancer patients living with HIV. The study was recently published in JAMA Oncology. It focused on whether a relatively new class of drugs called checkpoint inhibitors are safe and effective in patients with advanced cancer who also live with HIV. A concern has been that checkpoint inhibitors manipulate the immune systems and hence may have an adverse effect on virus reactivation in patients with HIV infection.
Chul Kim, Assistance Professor Georgetown